Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Withings, a French medtech company known for its remote monitoring devices, has multiple new services on display at CES 2025.

CES 2025: Cardiologist check-ups, AI-powered smart mirrors coming to heart patients’ homes

Healthcare companies from all over the world are showing off their newest cardiovascular offerings at CES 2025 in Las Vegas.

Surgeons Operating On Patient

Radial secondary access during TAVR limits complications

Radial access is already the primary choice for many cardiologists performing PCI due to a lower risk of complications. The same appears to be true for secondary access during TAVR.

oximeter

FDA issues proposed guidance for improving reliability of pulse oximeters

The devices struggle to accurately read blood-oxygen levels in patients with darker and thicker skin. The FDA hopes that changes in design and improved clinical trials will improve clinical efficacy.

Transcatheter pulmonary valve replacement (TPVR) with Medtronic’s self-expanding Harmony valve is both safe and effective after more than a year, according to new real-world data published in the Journal of the American College of Cardiology.[1]

Medtronic’s Harmony TPVR system gains CE mark approval

The FDA-approved Harmony TPVR system is now available to patients across the EU. Nina Goodheart, president of Medtronic’s structural heart and aortic business, described the news as a "significant milestone."

Semaglutide linked to ‘significant and consistent’ benefits for heart bypass surgery patients

The popular GLP-1 receptor agonist appears to help limit adverse events and new-onset diabetes in patients with a history of CABG. Researchers shared the full study in the Journal of the American College of Cardiology.

Michael Reardon, MD, said monitoring under expansion would have made Acurate Neo2 non-inferior to current TAVR valves in the ACURATE IDE trial.

The primary reason Boston Scientific’s TAVR valve fell short in clinical trial

Michael Reardon, MD, co-principal investigator of the ACURATE IDE trial, discussed updated data on what may have impacted that study's findings.

From left to right: Sunita Ferns, MD; Mark Plunkett, MD; Harma Turbendian, MD. Images courtesy of OSF Healthcare.

History made: Young child treated with new heart device for very first time

A care team in Illinois has performed the first heart procedure of its kind on a two-year-old patient diagnosed with Brugada syndrome. 

Thumbnail

‘A victory for TAVR’: How treatment impacts elderly patients in their last year of life

New research out of Denmark explored how undergoing TAVR may or may not influence the final year of a patient's life.

Displaying 857 - 864 of 6783
Design by Adaptive Theme